InMed Pharmaceuticals Inc. ( INM) - Key Metrics
INM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $3.28 | -$2.71 | -$2.95 | -$2.95 |
| 2024Q4 | $0 | $0 | $0 | $0 |
| 2024Q3 | $0.12 | -$0.18 | -$0.20 | -$0.20 |
| 2024Q2 | $0.16 | -$0.19 | -$0.23 | -$0.23 |
| 2024Q1 | $0.51 | -$0.76 | -$0.65 | -$0.65 |
INM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -0.02 |
| 2024Q4 | ? | -247.39 |
| 2024Q3 | ? | -0.51 |
| 2024Q2 | ? | -0.56 |
| 2024Q1 | ? | -0.23 |
INM
Price: $1.49
52 week price:
Earnings Per Share: -6.09 USD
P/E Ratio: -0.14
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 53653
Market Capitalization: 2.8 million